CN Patent

CN120897764A — 包含阿西替尼多晶型物iv的眼部植入物

Assigned to Serpus Ophthalmology Co · Expires 2025-11-04 · 1y expired

What this patent protects

本发明涉及含有分散在水凝胶中的阿西替尼的持续释放生物可降解眼部植入物，其用于长时间治疗视网膜疾病。

USPTO Abstract

本发明涉及含有分散在水凝胶中的阿西替尼的持续释放生物可降解眼部植入物，其用于长时间治疗视网膜疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN120897764A
Jurisdiction
CN
Classification
—
Expires
2025-11-04
Drug substance claim
No
Drug product claim
No
Assignee
Serpus Ophthalmology Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.